Berdazimer Topical Dosage
Applies to the following strengths: 10.3%
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Molluscum Contagiosum
Apply an even thin layer to each Molluscum contagiosum lesion once a day.
Duration of therapy: Up to 12 weeks
Comments:
- Mix equal amounts (0.5 mL) of gel from tubes A and B before application.
- Allow the gel to dry for 10 minutes after application.
- Wash hands after applying gel unless hands are being treated.
Use: For the topical treatment of molluscum contagiosum
Usual Pediatric Dose for Molluscum Contagiosum
Apply an even thin layer to each Molluscum contagiosum lesion once a day.
Duration of therapy: Up to 12 weeks
Comments:
- Mix equal amounts (0.5 mL) of gel from tubes A and B before application.
- Allow the gel to dry for 10 minutes after application.
- Wash hands after applying gel, unless hands are being treated.
Use: For the topical treatment of molluscum contagiosum in pediatric patients 1 year of age and older
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS: None
Safety and efficacy have not been established in patients younger than 1 year.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available.
Other Comments
Administration advice:
- This product must be mixed together immediately before application.
- Avoid application to uninvolved skin and avoid transfer of applied gel to other areas, including the eyes.
- Avoid swimming, bathing, or washing for 1 hour after applying gel.
- Wash hands after applying this product unless hands are being treated.
- Do not premix or store mixed gel.
- This drug is for topical use only and not for ophthalmic, oral, or intravaginal use.
Storage requirements:
- Prior to dispensing, store in a refrigerator between 2C to 8C (36F to 46F). Do not freeze.
- After dispensing, store at room temperature, between 20C to 25C (68F and 77F) in a dry location.
- Discard 60 days after removing from refrigerator.
Preparation technique:
- The manufacturer product information should be consulted.
Patient advice:
- Read the US FDA-approved patient labeling (Patient Information and Instructions for Use).
- If signs or symptoms of application site reactions lasting more than 24 hours occur, then discontinue this drug and seek medical attention immediately.
- Hands should be washed after applying this drug (unless hands are being treated). Avoid transferring the product to other areas of the skin, including the eyes.
More about berdazimer topical
- berdazimer topical consumer information
- Compare alternatives
- Side effects
- During pregnancy
- Drug class: miscellaneous topical agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.